Clinical Trial Update: S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial update of abiraterone acetate (S1014) in prostate cancer patients who have undergone initial hormone therapy. Results from the completed trial hav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-05-05